Hypokalemia
16
2
3
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.3%
1 terminated out of 16 trials
88.9%
+2.4% vs benchmark
44%
7 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (16)
Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat
Targeted Potassium Levels for Prevention of ICD Therapy
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients
Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE)
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels
Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium
Outcome of Patients With Primary Aldosteronism
The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis
Hypomagnesemia Associated With Proton-Pump Inhibitor Use
Intravenous Fluids in Hospitalised Children
Efficacy of KCl Plus 0.9%NaCl Compare With KCl Plus 0.45%NaCl
Comparison of Dexmedetomidine and Remifentanil Infusion During CABG
Safety of Continuous Potassium Chloride Infusion in Critical Care
Effect of Licorice and Hydrochlorothiazide on Plasma Potassium